Eslicarbazepine acetate in the management of refractory bipolar disorder

Kamal Nath, Arnab Bhattacharya, Samir Kumar Praharaj

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Eslicarbazepine acetate is a novel third-generation antiepileptic related to carbamazepine and oxcarbazepine with a benign adverse effect profile. We report a patient with bipolar mania with intolerance to multiple antimanic drugs, responding to eslicarbazepine without any serious adverse effect.

Original languageEnglish
Number of pages1
JournalClinical Neuropharmacology
Volume35
Issue number6
DOIs
Publication statusPublished - 01-11-2012

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Eslicarbazepine acetate in the management of refractory bipolar disorder'. Together they form a unique fingerprint.

  • Cite this